Timothy Walbert was appointed chair of the board of directors of Latigo Biotherapeutics, a clinical-stage biotechnology company developing best-in-class non-opioid pain medicines.
In 2025, Ali Calamoneri ’18 and Noah Fulcomer ’19 spent five months hiking the Pacific Crest […]
Does AI still need humans? Is fentanyl airborne? How did certain vaccines and monuments become so […]
Timothy Walbert was appointed chair of the board of directors of Latigo Biotherapeutics, a clinical-stage biotechnology company developing best-in-class non-opioid pain medicines.
